Published in Infect Control Hosp Epidemiol on November 01, 2001
Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Technol (2009) 1.72
Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose. J Diabetes Sci Technol (2010) 1.48
Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission. J Infect Dis (2013) 1.26
Managing occupational risks for hepatitis C transmission in the health care setting. Clin Microbiol Rev (2003) 1.13
National athletic trainers' association position statement: skin diseases. J Athl Train (2010) 1.12
Prevalence of bacterial contamination of glucose test strips in individual single-use packets versus multiple-use vials. J Diabetes Sci Technol (2013) 0.87
Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients. Eur J Epidemiol (2004) 0.83
Hospital cluster of HBV infection: molecular evidence of patient-to-patient transmission through lancing device. PLoS One (2012) 0.82
Transmission of hepatitis C virus during computed tomography scanning with contrast. Emerg Infect Dis (2008) 0.77
Hepatitis C virus infection in Egyptian children with type 1 diabetes mellitus: A single center study. Indian J Endocrinol Metab (2014) 0.76
Health care-associated hepatitis C virus infection. World J Gastroenterol (2014) 0.76
The bacterial contamination rate of glucose meter test strips in the hospital setting. Saudi Med J (2016) 0.75
Safer generation of spring-loaded fingerstick lancets. Infect Control Hosp Epidemiol (2002) 0.75
Acute Esophageal Necrosis: An Update. N Am J Med Sci (2016) 0.75
Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis C surveillance system in France. Epidemiol Infect (2007) 0.75
Acute hepatitis C virus infection related to capillary blood glucose meter. Saudi Med J (2016) 0.75
Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol (2000) 5.26
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol (2002) 4.55
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology (2001) 4.28
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature (1990) 4.10
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A (1997) 3.88
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med (1995) 3.41
Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol (1992) 3.35
Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci U S A (1994) 2.69
High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology (1993) 2.65
Cyclin A is required in S phase in normal epithelial cells. Biochem Biophys Res Commun (1992) 2.55
Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. Ann Intern Med (2000) 2.43
Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care (2001) 2.37
State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci U S A (1981) 2.37
Detection of hepatitis B virus sequences in serum by using in vitro enzymatic amplification. J Virol Methods (1988) 2.36
Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med (1985) 2.29
Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group. Diabetes Care (1998) 2.23
Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nat Genet (1997) 2.01
Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology (1995) 2.00
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report. Gut (2000) 1.94
Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol (1998) 1.91
Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis (1992) 1.90
Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes. Diabetes Care (2001) 1.88
Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner. Hepatology (2001) 1.84
Hepatitis C virus biology. Cell Death Differ (2003) 1.83
Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology (1998) 1.74
Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut (2005) 1.66
Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene (1999) 1.63
Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology (1999) 1.60
Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res (2001) 1.57
Epidemiological and virological analysis of couples infected with hepatitis C virus. Gut (1999) 1.55
The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology (1995) 1.54
Improvement of diabetic control and acceptability of a three-injection insulin regimen in diabetic adolescents. A multicenter controlled study. Diabetes Care (1993) 1.52
Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol (1993) 1.49
Molecular prenatal exclusion of familial partial androgen insensitivity (Reifenstein syndrome) Eur J Endocrinol (1994) 1.46
Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes (1998) 1.45
Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest (1992) 1.45
Effect of pregnancy on chronic hepatitis C: a case-control study. Lancet (2000) 1.43
Defective hepatitis B virus particles are generated by packaging and reverse transcription of spliced viral RNAs in vivo. J Virol (1991) 1.41
Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases. J Hepatol (2000) 1.40
Triggering of acute alcoholic hepatitis by alpha-interferon therapy. J Hepatol (1999) 1.39
The course of hepatitis C virus infection after liver transplantation. Hepatology (1994) 1.38
Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N Engl J Med (1982) 1.37
Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. J Virol (2001) 1.36
Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology (1993) 1.36
A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome. Genomics (1995) 1.30
A novel gene (HIP) activated in human primary liver cancer. Cancer Res (1992) 1.30
Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes. Diabet Med (1998) 1.29
Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells. Hepatology (1999) 1.28
Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats. Diabetologia (1994) 1.26
Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging. Oncogene (2001) 1.26
Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology (1993) 1.26
Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. J Natl Cancer Inst (2000) 1.23
In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J Gen Virol (1998) 1.23
Overexpression of human cyclin A advances entry into S phase. Oncogene (1995) 1.22
Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J Gen Virol (1994) 1.15
Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol (1999) 1.15
Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes. J Hepatol (1995) 1.14
Frequent and early in utero HIV-1 infection. AIDS Res Hum Retroviruses (1991) 1.13
Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology (1997) 1.10
Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome. Oncogene (1998) 1.10
Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene (1992) 1.10
Absence of hepatitis C virus and detection of hepatitis G virus/GB virus C RNA sequences in the semen of infected men. J Infect Dis (1998) 1.09
Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha. Mol Cell Biol (1999) 1.09
Partial nucleotide sequence analysis of a French hepatitis C virus: implications for HCV genetic variability in the E2/NS1 protein. J Gen Virol (1991) 1.08
Immunohistochemical evidence for human immunodeficiency virus-1 infection of liver Kupffer cells. Hum Pathol (1990) 1.06
X g and X chromosome inactivation. Lancet (1971) 1.06
Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection. Am J Clin Pathol (1999) 1.05
Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol (1999) 1.04
HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM). Tissue Antigens (1982) 1.04
Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with flow cytometric parameters. J Hepatol (1995) 1.04
Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence. J Urol (2000) 1.03
Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections. J Med Virol (1997) 1.02
Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens. J Infect Dis (1999) 1.01
HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut (2010) 1.00
Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol (1992) 1.00
Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. J Hepatol (1997) 0.99
Identification and transmission of hepatitis B virus-related variants. Proc Natl Acad Sci U S A (1986) 0.99
Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. Int J Cancer (1999) 0.99
Pubertal gynecomastia due to an estrogen-producing adrenal adenoma. J Pediatr (1979) 0.98
Permissiveness of human biliary epithelial cells to infection by hepatitis C virus. Hepatology (1999) 0.98
Detection of HIV1 RNA and p24 antigen in HIV1-infected human liver. Res Virol (1990) 0.98
[Prevalence and genotypes of hepatitis C virus in blood donors and in patients with chronic liver disease and hepatocarcinoma in a Chilean population]. Rev Med Chil (1998) 0.97
Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells. Am J Pathol (1999) 0.97
Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors. J Virol (1988) 0.97
Hepatitis B virus DNA in Dane particles: evidence for the presence of replicative intermediates. J Infect Dis (1985) 0.97
MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis. J Hepatol (1993) 0.96
Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease. J Hepatol (1986) 0.95
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology (1997) 0.95